These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19250402)

  • 1. Two pediatric cases of primary cutaneous B-cell lymphoma and review of the literature.
    Sharon V; Mecca PS; Steinherz PG; Trippett TM; Myskowski PL
    Pediatr Dermatol; 2009; 26(1):34-9. PubMed ID: 19250402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous B-cell lymphoma with histologic features of mycosis fungoides.
    Chiang S; DiCaudo DJ; Valdez R; Swanson DL
    J Am Acad Dermatol; 2010 Feb; 62(2):320-3. PubMed ID: 19811849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
    Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
    Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.
    Hodak E; Feuerman H; Barzilai A; David M; Cerroni L; Feinmesser M
    Arch Dermatol; 2010 Feb; 146(2):175-82. PubMed ID: 20157029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas.
    Kerl H; Kodama K; Cerroni L
    J Dermatol Sci; 2004 May; 34(3):167-75. PubMed ID: 15113586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
    J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and experimental skin-directed therapies for cutaneous lymphomas.
    Farkas A; Kemeny L; French LE; Dummer R
    Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
    Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
    Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous B-cell lymphoma: classification and treatment.
    Willemze R
    Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary subcutaneous B-cell lymphoma: case report and literature review.
    Alaibac M; Bordignon M; Pennelli N; Aversa S; Fornasa CV; Chiarion V
    Acta Derm Venereol; 2008; 88(2):151-4. PubMed ID: 18311443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
    Vural F; Saydam G; Cagirgan S; Ertekin B; Hekimgil M; Unal I; Soydan S; Tombuloglu M
    Int J Dermatol; 2008 Jul; 47(7):675-80. PubMed ID: 18613872
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
    Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.